CAPS is associated with NLRP3 pathogenic variants, which lead to the hyperactivation of the NLRP3 inflammasome, resulting in the inappropriate release of inflammatory cytokines such as interleukin-1β (IL-1β) [2]. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.